Recent News

• 05.22.2025 - Aptevo Therapeutics Announces 1-for-20 Reverse Stock Split as part of Nasdaq Compliance Plan
• 05.15.2025 - Aptevo Therapeutics Reports 1Q25 Financial Results And Provides an Update on Mipletamig
• 05.08.2025 - Aptevo Therapeutics Provides Program Update for Bispecific APVO711, a PD-L1 X CD40 that Combines a Checkpoint Inhibitor and Immune Activation

Recent Filings

• 05.22.2025 - 8-K Current report
• 05.22.2025 - EX-99.1 EX-99.1
• 05.22.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 05.15.2025 - EX-99.1 EX-99.1
• 05.15.2025 - 8-K Current report
• 05.15.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.13.2025 - RW Registration Withdrawal Request
• 05.13.2025 - RW Registration Withdrawal Request
• 05.13.2025 - S-1 General form for registration of securities under the Securities Act of 1933
• 05.02.2025 - S-3 Registration statement under Securities Act of 1933